BRONCHIOLITIS OBLITERANS
Clinical trials for BRONCHIOLITIS OBLITERANS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to halt deadly lung scarring in transplant patients
Disease control Recruiting nowThis study is testing a drug called belumosudil in adults who have developed early or new lung scarring (Bronchiolitis Obliterans Syndrome) after a stem cell transplant. The goal is to see if the drug can improve lung function and stop the scarring from getting worse. About 45 pa…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists search for early warning signs in devastating lung condition
Knowledge-focused Recruiting nowThis study aims to understand a specific type of cell found in patients with bronchiolitis obliterans syndrome (BOS), a serious lung condition that can occur after a stem cell or lung transplant. Researchers will collect cell samples from 15 patients during their routine medical …
Matched conditions: BRONCHIOLITIS OBLITERANS
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC